EUVIMEDEUVIMED entdecken
Übersichtsarbeit

RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec

Katarina Stingl iD, Claudia Priglinger iD, Philipp Herrmann

Klinische Monatsblätter für Augenheilkunde · 01.03.2024 · 241 (03) · 259-265

DOI: 10.1055/a-2227-3671 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.03.2024. Verfasst von Katarina Stingl und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Eye Hospital, Center for Ophthalmology, University of Tübingen, Germany. Hauptthemen laut MEDLINE: Night Blindness, Retinal Dystrophies, Retinitis Pigmentosa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal dystrophies linked to the RPE65 gene are mostly fast-progressing retinal diseases, with childhood onset of night blindness and progressive visual loss up to the middle adult age. Rare phenotypes linked to this gene are known with congenital stationary night blindness or slowly progressing retinitis pigmentosa, as well as an autosomal dominant c.1430A>G (p.Asp477Gly) variant. This review gives an overview of the current knowledge of the clinical phenotypes, as well as experience with the efficacy and safety of the approved gene augmentation therapy voretigene neparvovec.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Night BlindnessRetinal DystrophiesRetinitis PigmentosaAdultChildHumanscis-trans-IsomerasesGenetic TherapyMutationPhenotypeRetinoid Isomerohydrolase

Substanzen

cis-trans-IsomerasesRetinoid Isomerohydrolase

Autor:innen und Institutionen

  • University Eye Hospital, Center for Ophthalmology, University of Tübingen, Germany.
  • Department of Ophthalmology, Ludwig-Maximilians-University Hospital, LMU Munich, Germany.
  • University Eye Hospital Bonn, University Hospital Bonn, Germany.

ORCID-Profile: Katarina Stingl, Claudia Priglinger

Zitieren

APA

Stingl, K., Priglinger, C., & Herrmann, P. (2024). RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec. Klinische Monatsblätter für Augenheilkunde, 241(03), 259-265. https://doi.org/10.1055/a-2227-3671

Vancouver

Stingl K, Priglinger C, Herrmann P. RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec. Klinische Monatsblätter für Augenheilkunde. 2024;241(03):259-265. doi:10.1055/a-2227-3671

BibTeX
@article{Stingl2024,
  author = {Stingl, Katarina and Priglinger, Claudia and Herrmann, Philipp},
  title = {RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec},
  journal = {Klinische Monatsblätter für Augenheilkunde},
  year = {2024},
  volume = {241},
  number = {03},
  pages = {259--265},
  doi = {10.1055/a-2227-3671}
}
Kostenlos starten →